Last reviewed · How we verify
NCT05410080
the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome
trial testing Fasting blood sugar, 2 hours postprandial, HBA1C ,Ultrasound and Doppler study in Gestational Diabetes in 140 participants. Status unknown.
20 September 2022
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 140 |
| Start date | 15 June 2022 |
| Primary completion | 20 September 2022 |
| Estimated completion | 20 October 2022 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- Fasting blood sugar, 2 hours postprandial, HBA1C ,Ultrasound and Doppler study
Conditions studied
- Gestational Diabetes — all drugs for Gestational Diabetes →
- Pre-Gestational Diabetes — all drugs for Pre-Gestational Diabetes →
- IUGR — all drugs for IUGR →
- Macrosomia, Fetal — all drugs for Macrosomia, Fetal →
Sponsor
Cairo University
Who can join
Adults 18 to 35, female only, with Gestational Diabetes or Pre-Gestational Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine and evaluate the diagnostic performance of Doppler sonography of umbilical artery (UA), fetal middle cereberal artery (MCA), ductus venosus (VD) and umbilical vein (UV) for prediction of adverse perinatal outcome among diabetic pregnant women.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Unraveling the complex web: pathogenesis and prevention of gestational diabetes mellitus-related fetal overgrowth.
Jiang XY, Chen DW, Duan T, Zhang JD, et al · · 2026 · PMID 41710943 · DOI 10.3389/fcell.2026.1744305
Verify or expand the search:
- PubMed search for NCT05410080
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gestational Diabetes
Currently open trials in the same condition.
- NCT07171684 — Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) · NA · recruiting
- NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
- NCT06571487 — Growth Hormone Resistance of Beta-cells · recruiting
- NCT07336914 — Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes · NA · recruiting
- NCT07174245 — Pregnancy and Postpartum CGM in GDM · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05410080 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 23 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05410080.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing